Shimatsu, A. (2022) “OSILODROSTAT IS EFFECTIVE AND WELL- TOLERATED IN ASIAN AND NON-ASIAN PATIENTS WITH CUSHING’S DISEASE: RESULTS FROM LINC 3 (PHASE III STUDY)”, Journal of the ASEAN Federation of Endocrine Societies, 37(2), pp. 75–76. doi: 10.15605/jafes.037.AFES.118.